QIAGEN and Neuron23TM Inc., an early-stage biotechnology company focused on creating precision medications for genetically defined neurological and immunological illnesses,...
Read more
Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer....
Read more
Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to...
Read more
Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will...
Read more
The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and...
Read more
Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in...
Read more
Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their...
Read more
The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome...
Read more
The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific...
Read more
In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
